Clinical Infections and Vaccines

CIVClinical Infections and Vaccines (CIV) – formerly part of the Antimicrobial Agents and Infectious Diseases track – will cover a range of important topics relevant to infectious diseases and their impact on human health. The latest information on common healthcare-associated infections, such as Clostridium difficile, pneumonia, and complicated urinary tract infections, will be featured in this track. The science in this track works to bring together angstrom-level discovery and clinical research to reduce the burden of infectious diseases around the globe. 


CIV01: Clinical Studies of Adult Infectious Diseases, including Clinical Trials and Diseases caused by Bacteria, Viruses, Fungi, Prions or Parasites

CIV02: Infection Prevention and Control: Healthcare-associated and Surgical Infections and Clinical Epidemiology

CIV03: Global Health 

CIV04: Transplant Infectious Diseases 

CIV05: Pediatric Infectious Diseases

CIV06: Vaccines and Immunization Science


Hear from Top Speakers

Keith Kaye
University of Michigan
Michigan State University 
Elizabeth Miller
Public Health England
Jacques Schrenzel
University of Geneva Hospital

See who else is speaking. SEARCH ALL SPEAKERS IN TRACK.


Attend Innovative Sessions

Advances in Device-related Infection Prevention and Management
June 8, 2018 • 7:30 a.m. – 8:30 a.m. 

Metagenomics for Clinical Infectious Diseases
June 8, 2018 • 1:30 p.m. – 4:00 p.m. 

Update on the Global Threat of Zika Virus 
June 8, 2018 • 1:30 p.m. – 2:15 p.m. 

CMV Resistance: Limited Options but Promising Future
June 9, 2018 • 1:30 p.m. – 4:00 p.m. 


RegisterNow blue